News and Trends 24 Oct 2019German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround The German company Vivoryon Therapeutics has raised €43M on Euronext Amsterdam to fund a phase IIb trial of a drug… October 24, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Oct 2017German Drug to Stop the Progression of Alzheimer’s Enters Phase IIb Probiodrug is ready to start a Phase IIb trial with an Alzheimer's drug that prevents the formation of Aβ plaques before… October 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2017German Scientists Publish New Mechanism of Action Against Alzheimer’s Researchers at the German biotech Probiodrug have published today the detailed mechanism of action of a drug that might succeed in… August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jun 2017German Biotech Unveils Positive Phase II Results for Alzheimer’s Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead candidate PQ912 in patients with… June 12, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2017A Dutch University Hospital has Halted Amyloid Beta Drug Studies Despite the popularity of amyloid beta-targeting drugs, none have managed to pass late stage clinical trials, prompting UMC Radboud to… February 10, 2017 - 3 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Jan 201710 Hot European Biotechs to Observe in 2017 🚀 New year, new list: here are the 10 hottest Biotech companies I will watch closely in 2017 and why. This… January 3, 2017 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2016What Does ‘Anti-Aging Treatment’ Mean in Biotech? Beyond filling in wrinkles with cosmetics, how do you solve a problem like aging? Here’s how biotech is sinking its… December 20, 2016 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2016Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments? Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s not over yet. Probiodrug explains… December 19, 2016 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2016Leading German Biotech recruits New talent for Fight against Alzheimer’s Probiodrug (Germany) has hired Mark Booth as Chief Business Officer to propel this Pharma's global strategy. Among other important roles,… March 24, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2015To IPO or not to IPO when you are a Biotech company? #BIO-Europe 2015 This is the second conference I attended at BIO-Europe. This is an interesting topic when you look at the different… November 3, 2015 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 20152014, the Biggest Year Ever for European Biotech IPOs There is no need to say it: biotechnology is the latest trend. A worldwide bio-boom has shaken stock markets throughout… February 6, 2015 - 3 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email